Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 48  Show

Literature citations Results

Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor.

Gornalusse G.G., Mummidi S., Gaitan A.A., Jimenez F., Ramsuran V., Picton A., Rogers K., Manoharan M.S., Avadhanam N., Murthy K.K. et al.

Proc. Natl. Acad. Sci. U.S.A. 112:E4762-71(2015) · Mapped (99)

Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.

Huik K., Avi R., Uibopuu H., Pauskar M., Margus T., Karki T., Krispin T., Kool P., Ruutel K., Talu A. et al.

J. Acquir. Immune Defic. Syndr. 66:239-244(2014) · Mapped (99)

CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users.

Huik K., Avi R., Carrillo A., Harper N., Pauskar M., Sadam M., Karki T., Krispin T., Kongo U.K., Jermilova T. et al.

PLoS ONE 8:e70561-e70561(2013) · Mapped (99)

Important role of CCR2 in a murine model of coronary vasculitis.

Martinez H.G., Quinones M.P., Jimenez F., Estrada C., Clark K.M., Suzuki K., Miura N., Ohno N., Ahuja S.K., Ahuja S.S.

BMC Immunol. 13:56-56(2012) · Mapped (5)

The CC chemokine receptor 5 regulates olfactory and social recognition in mice.

Kalkonde Y.V., Shelton R., Villarreal M., Sigala J., Mishra P.K., Ahuja S.S., Barea-Rodriguez E., Moretti P., Ahuja S.K.

Neuroscience 197:153-161(2011) · Mapped (4)

Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population.

Mamtani M., Mummidi S., Ramsuran V., Pham M.H., Maldonado R., Begum K., Valera M.S., Sanchez R., Castiblanco J., Kulkarni H. et al.

J. Infect. Dis. 203:1590-1594(2011) · Mapped (100)

Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women.

Ramsuran V., Kulkarni H., He W., Mlisana K., Wright E.J., Werner L., Castiblanco J., Dhanda R., Le T., Dolan M.J. et al.

Clin. Infect. Dis. 52:1248-1256(2011) · Mapped (23)

Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease.

Shimizu C., Matsubara T., Onouchi Y., Jain S., Sun S., Nievergelt C.M., Shike H., Brophy V.H., Takegawa T., Furukawa S. et al.

J. Hum. Genet. 55:779-784(2010) · Mapped (22)

Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.

Mamtani M., Matsubara T., Shimizu C., Furukawa S., Akagi T., Onouchi Y., Hata A., Fujino A., He W., Ahuja S.K. et al.

PLoS ONE 5:e11458-e11458(2010) · Mapped (110)

Reply to: "Experimental aspects of copy number variant assays at CCL3L1".

He W., Kulkarni H., Castiblanco J., Shimizu C., Aluyen U., Maldonado R., Carrillo A., Griffin M., Lipsitt A., Beachy L. et al.

Nat. Med. 15:1117-1120(2009) · Mapped (1)

Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases.

Mamtani M., Anaya J.M., He W., Ahuja S.K.

Genes Immun. 11:155-160(2010) · Mapped (7)

The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

Kulkarni H., Marconi V.C., He W., Landrum M.L., Okulicz J.F., Delmar J., Kazandjian D., Castiblanco J., Ahuja S.S., Wright E.J. et al.

Blood 114:2783-2792(2009) · Mapped (23)

Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.

Camargo J.F., Kulkarni H., Agan B.K., Gaitan A.A., Beachy L.A., Srinivas S., He W., Anderson S., Marconi V.C., Dolan M.J. et al.

J. Infect. Dis. 199:1872-1882(2009) · Mapped (8)

Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children.

Shostakovich-Koretskaya L., Catano G., Chykarenko Z.A., He W., Gornalusse G., Mummidi S., Sanchez R., Dolan M.J., Ahuja S.S., Clark R.A. et al.

AIDS 23:679-688(2009) · Mapped (2)

CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.

Camargo J.F., Quinones M.P., Mummidi S., Srinivas S., Gaitan A.A., Begum K., Jimenez F., VanCompernolle S., Unutmaz D., Ahuja S.S. et al.

J. Immunol. 182:171-182(2009) · Mapped (24)

Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.

Kulkarni H., Marconi V.C., Agan B.K., McArthur C., Crawford G., Clark R.A., Dolan M.J., Ahuja S.K.

PLoS ONE 3:e3671-e3671(2008) · Mapped (100)

HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.

Catano G., Kulkarni H., He W., Marconi V.C., Agan B.K., Landrum M., Anderson S., Delmar J., Telles V., Song L. et al.

PLoS ONE 3:e3636-e3636(2008) · Mapped (1,775)

CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

Kulkarni H., Agan B.K., Marconi V.C., O'Connell R.J., Camargo J.F., He W., Delmar J., Phelps K.R., Crawford G., Clark R.A. et al.

PLoS ONE 3:e3165-e3165(2008) · Mapped (100)

Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

He W., Neil S., Kulkarni H., Wright E., Agan B.K., Marconi V.C., Dolan M.J., Weiss R.A., Ahuja S.K.

Cell Host Microbe 4:52-62(2008) · Mapped (23)

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.

Burt T.D., Agan B.K., Marconi V.C., He W., Kulkarni H., Mold J.E., Cavrois M., Huang Y., Mahley R.W., Dolan M.J. et al.

Proc. Natl. Acad. Sci. U.S.A. 105:8718-8723(2008) · Mapped (11)

Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.

Catano G., Agan B.K., Kulkarni H., Telles V., Marconi V.C., Dolan M.J., Ahuja S.K.

J. Infect. Dis. 198:72-80(2008) · Mapped (103)

CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.

Mamtani M., Rovin B., Brey R., Camargo J.F., Kulkarni H., Herrera M., Correa P., Holliday S., Anaya J.M., Ahuja S.K.

Ann. Rheum. Dis. 67:1076-1083(2008) · Mapped (100)

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

Dolan M.J., Kulkarni H., Camargo J.F., He W., Smith A., Anaya J.M., Miura T., Hecht F.M., Mamtani M., Pereyra F. et al.

Nat. Immunol. 8:1324-1336(2007) · Mapped (100)

Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt.

Quinones M.P., Kalkonde Y., Estrada C.A., Jimenez F., Ramirez R., Mahimainathan L., Mummidi S., Choudhury G.G., Martinez H., Adams L. et al.

Mol. Cell. Neurosci. 37:96-109(2008) · Mapped (30)

CC chemokine receptor 5 influences late-stage atherosclerosis.

Quinones M.P., Martinez H.G., Jimenez F., Estrada C.A., Dudley M., Willmon O., Kulkarni H., Reddick R.L., Fernandes G., Kuziel W.A. et al.

Atherosclerosis 195:e92-103(2007) · Mapped (2)

1 to 25 of 48  Show